High-definition tDCS targeting the primary somatosensory cortex for adolescent bipolar depression
Official title: High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Targeting the Primary Somatosensory Cortex for Bipolar Depression in Adolescents: A Randomized Double-Blind Controlled Trial
Run by Jiangsu Province Nanjing Brain Hospital · NCT07246044 · Data updated 2026-11-12
This trial will try high-definition transcranial direct current stimulation (HD-tDCS) to reduce depressive symptoms in adolescents aged 12–18 with bipolar depression, compared with a sham procedure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Jiangsu Province Nanjing Brain Hospital Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | October 15, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07246044 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 12–18 years old, meet DSM criteria for bipolar disorder with a current moderate-to-severe depressive episode (HAMD ≥17 and YMRS <12), are on a stable psychotropic medication regimen, and can provide informed consent with parental permission as required.
✕Probably not a fit
Patients with prior brain stimulation (rTMS/tDCS/ECT), uncontrolled or unstable medication or manic symptoms, inability to undergo MRI, or who cannot attend the required in-person twice-daily sessions are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, sham-controlled trial enrolling adolescents with bipolar depression to receive either active HD-tDCS or sham stimulation alongside routine clinical care. Active or sham stimulation is delivered for 10 consecutive days with two 20-minute sessions per day. Multimodal assessments are performed at baseline, mid-treatment, and post-treatment and include clinical scales, neurocognitive testing, structural and functional MRI, blood biomarkers, EEG, photoplethysmography, voice and facial metrics, sleep, and behavioral data. The study also seeks objective biomarkers and neurobiological mechanisms that predict or accompany clinical response to S1-targeted HD-tDCS.
Why it matters
Potential benefit: If successful, this noninvasive approach could provide a tolerable, clinic-delivered option to reduce depressive symptoms in adolescents with bipolar disorder and help identify biomarkers to personalize care.
How similar studies have gone: Some adult tDCS studies have shown modest antidepressant effects, but HD-tDCS targeting the primary somatosensory cortex in adolescents with bipolar depression is a novel and relatively untested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between 12 and 18 years of age; * Participants fulfill the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnostic criteria for bipolar disorder (BD). Participants are assessed by the Structured Clinical Interview for DSM-IV for Axis I Disorders (SCID-I, patients' age ≥18 years old), or the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K- SADS-PL, patients' age\< 18 years old); * A current moderate or severe depressive episode defined by HAMD≥17 and Young Mania Rating Scale (YMRS) \<12; * Participants receive a stable psychotropic medication regimen prior to randomization to the trial and are willing to remain on the stable regimen during the HD-tDCS treatment phase; * Participants and 1 or 2 parents (patients' age\< 18 years old) provide informed consent after the detailed description of the study. Exclusion Criteria: * Prior rTMS or tDCS or electroconvulsive therapy (ECT) treatment or standard psychological therapy within 6 months prior to screening; * Comorbidity of other DSM-IV axis I disorders or personality disorders; * Judged clinically to be at serious suicidal risk; * Diabetes mellitus, hypertension, vascular and infectious diseases and other major medical comorbidities; * Unstable medical conditions, e.g., severe asthma; * Neurological disorders, e.g., history of head injury with loss of consciousness for ≥ five minutes, cerebrovascular diseases, brain tumors and neurodegenerative diseases; * Mental retardation or autism spectrum disorder; * Contraindications to MRI (e.g., severe claustrophobia, pacemakers, metal implants); * Contraindications to tDCS (e.g., metal in head, history of seizure, EEG test suggesting high risk of seizure, known brain lesion); * Current drug/alcohol abuse or dependence; * Pregnant or lactating female.
Where it's running
-
Affiliated Nanjing Brain Hospital, Nanjing Medical University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Lifei Wang
- Email: lifeiwang@stu.njmu.edu.cn
- Phone: 86-13390599200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SCC Deep Brain Stimulation for Bipolar Depression in Bipolar I Patients
A small study tests whether deep brain stimulation of the subcallosal cingulate can help people with bipolar I depression who have not improved with other treatments, while monitoring brain signals to watch for manic switches.
-
EEG microstates and inflammatory biomarkers in older adults with major depression receiving ECT
This study tests how ECT affects brain wave patterns and inflammatory markers in people 55 and older with major depression.
-
Can moderate aerobic exercise combined with mild brain stimulation boost motor-cortex plasticity in older adults?
We will see if a single session of moderate aerobic exercise, alone or followed by mild brain stimulation (tDCS), helps boost motor-cortex plasticity in healthy older adults compared with younger adults.
-
Brain stimulation plus watching hand movements to improve hand recovery after chronic stroke
This project will test whether combining gentle brain stimulation with watching and practicing hand movements helps adults 6–24 months after stroke improve hand function.
-
RNA editing to predict antidepressant response in unipolar and bipolar depression
This project tests whether changes in RNA editing can predict how adults with unipolar or bipolar depression respond to antidepressant treatment.
-
Time Restricted Eating in Bipolar Disorder and Obesity
A randomized trial tests whether an 8-hour time-restricted eating plan helps adults with bipolar disorder who are overweight and mildly depressed compare to a wait-list control.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.